Invention Grant
- Patent Title: Serpine2 as a biomarker for IgA nephropathy
- Patent Title (中): Serpine2作为IgA肾病的生物标志物
-
Application No.: US12695907Application Date: 2010-01-28
-
Publication No.: US08178358B2Publication Date: 2012-05-15
- Inventor: Ann Chen , Shuk-Man Ka
- Applicant: Ann Chen , Shuk-Man Ka
- Applicant Address: TW Taipei
- Assignee: National Defense Medical Center
- Current Assignee: National Defense Medical Center
- Current Assignee Address: TW Taipei
- Agency: Ditthavong Mori & Steiner, P.C.
- Main IPC: G01N33/564
- IPC: G01N33/564 ; G01N33/53 ; G01N33/535 ; G01N33/563 ; C12Q1/00 ; C12Q1/25 ; C12Q1/68
Abstract:
The present invention provides a method for diagnosis or prognosis of IgA nephropathy in a subject based on detection of the expression level of one or more biomarker genes selected from the group consisting of thymosin β4 (Tmsb4), serine or cysteine proteinase inhibitor clade E member 2 (Serpine2), secreted phosphoprotein 1 (OPN), butyrophilin-like-2 (BTNL2), S100 calcium binding protein A8 (S100A8), Cystatin C (CysC), and any combination thereof.
Public/Granted literature
- US20110183349A1 BIOMARKERS FOR IgA NEPHROPATHY AND APPLICATIONS THEREOF Public/Granted day:2011-07-28
Information query
IPC分类:
